MedPath

ChemoCentryx, Inc.

ChemoCentryx, Inc. logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
1997-01-01
Employees
178
Market Cap
-
Website
http://www.chemocentryx.com

Clinical Trials

69

Active:66
Completed:2

Trial Phases

2 Phases

Phase 1:40
Phase 2:1

Drug Approvals

1

FDA:1

Drug Approvals

TAVNEOS

Approval Date
Feb 15, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (41 trials with phase data)• Click on a phase to view related trials

Phase 1
40 (97.6%)
Phase 2
1 (2.4%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.